GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED

Other languages Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Equities

600332

CNE000001733

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-08 pm EDT			5-day change	1st Jan Change
29.38 ^CNY	+0.69%		-0.64%	+2.73%

Jun. 27	Guangzhou Baiyunshan Pharmaceutical Secures Drug Registration for Erectile Dysfunction Tablets	MT
Jun. 19	Baiyunshan Pharmaceutical's Unit Gets Regulatory Nod to Add Specification for Dopamine Hydrochloride Injection	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guangzhou Baiyunshan Pharmaceutical Secures Drug Registration for Erectile Dysfunction Tablets	Jun. 27
Baiyunshan Pharmaceutical's Unit Gets Regulatory Nod to Add Specification for Dopamine Hydrochloride Injection	Jun. 18
Baiyunshan Pharmaceutical's Unit Gets Nod from Macao's Drug Regulator to Import, Export Pearl Powder	Jun. 17
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26
Baiyunshan Pharmaceutical's 2023 Profit Rises 2%	Mar. 18
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024	Mar. 15
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15
Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug	Mar. 01
Guangzhou Pharma Unit Gets Green Light to Trial Oral Liquid Drug	Feb. 09
Guangzhou Baiyunshan Pharmaceutical Arm Floats 1 Billion Yuan Biomedical VC Fund	Dec. 19
Guangzhou Baiyunshan Pharmaceutical Ends Spin-Off Plans, Seeks China Listing for Subsidiary	Dec. 19
Guangzhou Pharma Expands Scope of Drug Production License	Nov. 13
Guangzhou Baiyunshan Pharmaceutical's Profit Up 11% in Q3	23-10-30
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30
Baiyunshan Pharmaceutical Reports Increase in H1 Attributable Profit	23-09-13
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17
Guangzhou Pharma Registers Pain-Relief, Anti-Inflammatory Drugs in Russia	23-05-26
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2023	23-04-27
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Election of the Supervisor Representing the Employees of the 9th Session of the Supervisory Committee	23-04-25
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Dividend for the Year Ended 31 December 2022	23-03-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Equities

600332

CNE000001733

Other languages

Filters